top of page
![Pattern 5 [Converted]-01.png](https://static.wixstatic.com/media/51c62d_44f38c257d614130ace0f56455e9be12~mv2.png/v1/fill/w_980,h_718,al_c,q_90,usm_0.66_1.00_0.01,enc_avif,quality_auto/51c62d_44f38c257d614130ace0f56455e9be12~mv2.png)
Knowledge Center
Search


AI-CVD Investigators to Present at I-ELCAP’s 48th International Conference on Screening for Lung Cancer, October 9–11 in New York City
FOR IMMEDIATE RELEASE New York, NY — October 1, 2025 AI-CVD investigators will join global experts at the International Early Lung Cancer...


HeartLung.AI to Present Seven Pioneering AI-CVD™ and AI-CAC ™ Studies at European Society of Cardiology 2025 in Madrid
HeartLung AI will showcase seven abstracts at ESC 2025 on AI-CVD™, including novel AI-CAC™ for earlier, more sensitive heart disease...


HeartLung’s Leadership Featured on Cardiac Wire Show to Discuss New AI for Early Cardiac Chamber Enlargement Detection
FDA Breakthrough-designated AutoChamber™ AI uses routine CT scans to detect early cardiac chamber enlargement and prevent serious heart...


AI Osteoporosis Screening: HeartLung and Imaging Wire on Saving Lives and Reducing Costs
HeartLung's medical leadership featured on Imaging Wire Show to discuss breakthrough new AI for opportunistic osteoporosis screening....


AI-Powered CT Chamber Volumetry Predicts Heart Failure Risk As Accurately As MRI, New Study Shows
AI-based LV volume from CAC scans predicts heart failure over 15 years as accurately as MRI, enabling early detection from routine CT...


HeartLung.AI Showcases Breakthrough AI-CVD™ and AI-CAC™ Technologies at SCCT 2025 in Montreal
HOUSTON, TX, UNITED STATES, July 8, 2025 / EINPresswire.com / -- HeartLung.AI , a leader in AI-powered medical imaging solutions for...


Capitol Imaging Services Partners with HeartLung Technologies to offer Artificial Intelligence-Enabled Opportunistic Screening for Osteoporosis and Heart Disease
HeartLung Technologies partners with Capitol Imaging Services to offer Artificial Intelligence-Enabled Osteoporosis Screening (AutoBMD™ AI and AutoChamber™ AI) as an add-on to CT Scans in Alabama.


Celebrating the Multifaceted Talents of HeartLung's Distinguished Advisor, World-renowned Cardiologist, Dr. Robert A. Kloner: New Album Release "Fillmore Station"
Dr. Robert A. Kloner's latest musical endeavor, "Fillmore Station," is a blend of piano-based neo-classical and new age music.


AI-enabled opportunistic measurement of liver steatosis in coronary artery calcium scans predicts cardiovascular events and all-cause mortality:
Research shows HeartLung.AI’s AI-CVD™ improves traditional calcium scores in predicting heart disease risk and all-cause mortality


HeartLung Technologies Secures CMS Reimbursement for AutoChamber™ with New HCPCS Code
CMS has approved a new HCPCS code for AutoChamber™ AI reporting cardiac chambers volume and left ventricular mass in existing CT scans.


HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board
HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board.


HeartLung Technologies Presented 3 Groundbreaking AI Studies at BMEII 2025 New York Academy of Medicine
HeartLung showcases AI innovations at BMEII 2025, advancing healthcare with three scientific presentations.


HeartLung Technologies to launch AutoChamber™ AI at ACC 2025 and begin offering the AI services to healthcare providers
HeartLung Technologies to launch AutoChamber™ AI at ACC 2025 and begin offering the AI services to healthcare providers


HeartLung Technologies Selected as a Finalist for ACC 2025 Innovation Pitch Challenge
HeartLung Technologies Selected as a Finalist for ACC 2025 Innovation Pitch Challenge


SimonMed Imaging Partners with HeartLung.AI to Offer Artificial Intelligence-Based Osteoporosis Screening (AutoBMD™ AI) as an add-on to CT Scans Nationwide
SimonMed Imaging partners with HeartLung.AI to roll out AutoBMD™ AI for osteoporosis screening, enhancing preventive healthcare.


Part 23 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 2 Session 1: Mobile Vans
Dr. Robert Headrick discusses the evolution and success of mobile lung screening, highlighting key challenges and future innovations.


Part 22 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 2 Session 1: Tribute to Dr. James P. Smith
Honoring Dr. James P. Smith: A tribute to his contributions to LCAP, his enduring legacy in medical screening practices, and his family.


Paradigm shift in early detection: Lung cancer screening to comprehensive CT screening
This study indicates that comprehensive lifestyle modifications can significantly reduce cardiovascular risk factors.


Expert Panel Discusses AI-Driven Innovations in Cardiovascular Imaging: Key Takeaways from RSNA 2024
Experts at RSNA 2024 discuss AI's transformative impact on cardiovascular imaging, featuring insights from HeartLung.AI., Nurea, AI4MedImagi


Part 21 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 3: Reinventing Public Health in the Era of AI
Dr. Cheryl Healton, DrPH, emphasizes AI's role in public health, expanding lung screening, and managing smoking-related illnesses.
bottom of page
